permalink

0

BioProcess Algae and KD-Pharma Sign Commercial Supply Agreement for EPA-Rich Omega-3 Oils

Tweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Email this to someone ... thanks for sharing!

PORTSMOUTH, R.I., June 28, 2012 (GLOBE NEWSWIRE) — BioProcess Algae LLC, a sustainable algal feedstocks company, and KD-Pharma Bexbach GmbH, part of the Fat & Lipids Division of Bioseutica BV, a leading producer of highly purified pharmaceutical-grade Omega-3 fatty acids, announced today that they have entered a commercial supply agreement for the production of EPA-rich Omega-3 oils for use in concentrated EPA products for nutritional and/or pharmaceutical applications. Under the agreement, BioProcess Algae will supply microalgal oils which will be refined by KD-Pharma’s proprietary Supercritical Fluid Technology (KD-pur®) to produce highly-concentrated vegetable sourced EPA oils.

“We are very pleased to be able to work side-by-side with the industry leader for high-quality, highly-purified Omega-3 oils,” said Tim Burns, CEO of BioProcess Algae. “Our strategy is to continue to expand our co-location operations by growing high-quality feedstock at attractive prices. We intend to integrate additional off-takes to increase our operational efficiency, continue to gain economies of scale and to enhance profitability, and this agreement will enable us to expand commercial development toward this goal. We see many synergies with KD-Pharma and are excited to be working together.”

“Bioseutica is committed to identifying the highest quality and most sustainable sources for our natural ingredients,” said Peter Lembke, Vice President & Business Development Manager, Bioseutica. “From the beginning of our relationship, it was clear that BioProcess Algae shared our commitment to the environment without compromising product quality. Securing access to their algae oil will enable us to offer a unique, sustainable vegetable-based EPA-rich product that cannot be found in the marketplace today.”

Bioseutica is based in Lugano, Switzerland and offers purification, manufacturing and formulation for a variety of products including lysozyme and trypsin enzymes for nutritional and pharmaceutical applications. Bioseutica’s Fats & Lipids Division (KD-Pharma) is based in Bexbach, Germany and is the leading producer of highly-purified, pharmaceutical-grade Omega-3 fatty acids. Bioseutica is the only manufacturer with the ability to fully custom tailor the Omega-3 fatty acids formulation to unique specifications and manufactures the highest concentrated Omega-3s in the industry, including ultra-pure A1 Quality Oils. KD-Pharma has received numerous certifications and awards for its commitment to the environment. Their patented supercritical CO2-based KD-pur® technology produces no toxic impurities nor does it use toxic solvents. All byproducts are recycled or transformed into energy.

BioProcess Algae LLC is a Portsmouth, RI based leader in converting carbon dioxide (CO2) into sustainable algae feedstocks for human nutrition, animal feeds, green chemicals and biofuels. The company is currently running a commercial-scale facility that demonstrates the full co-location benefits of capturing carbon from an adjacent ethanol plant and converting it into high-quality feedstocks for downstream partners. The facility is integrated with the Green Plains Renewable Energy, Inc. ethanol plant in Shenandoah, Iowa as BioProcess Grower Harvester™ bioreactors have been tied directly into the plant’s CO2 exhaust gas since October 2009. BioProcess shareholders are CLARCOR Inc. (NYSE:CLC), a global provider of filtration products; BioProcess Holdings, a wastewater purification technology group; and Green Plains Renewable Energy, Inc. (Nasdaq:GPRE), North America’s fourth largest ethanol producer.

Source: BioProcess Algae

 

Leave a Reply

Required fields are marked *.